1. Academic Validation
  2. Thieno[2,3- b]thiophene Derivatives as Potential EGFRWT and EGFRT790M Inhibitors with Antioxidant Activities: Microwave-Assisted Synthesis and Quantitative In Vitro and In Silico Studies

Thieno[2,3- b]thiophene Derivatives as Potential EGFRWT and EGFRT790M Inhibitors with Antioxidant Activities: Microwave-Assisted Synthesis and Quantitative In Vitro and In Silico Studies

  • ACS Omega. 2022 Dec 3;7(49):45535-45544. doi: 10.1021/acsomega.2c06219.
Sanaa A Ahmed 1 Moumen S Kamel 2 Moustafa O Aboelez 3 Xiang Ma 4 Ahmed A Al-Karmalawy 5 Sayed A S Mousa 6 Elders Kh Shokr 7 H Abdel-Ghany 2 Amany Belal 8 9 Mohamed A El Hamd 10 11 Zafer S Al Shehri 12 Mahmoud Abd El Aleem Ali Ali El-Remaily 2
Affiliations

Affiliations

  • 1 Department of Pharmacology, Faculty of Medicine, Sohag University, Sohag82524, Egypt.
  • 2 Department of Chemistry, Faculty of Science, Sohag University, Sohag82524, Egypt.
  • 3 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University, Sohag82524, Egypt.
  • 4 School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430030, China.
  • 5 Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Giza12566, Egypt.
  • 6 Department of Chemistry, Faculty of Science, Al-Azhar University, Assiut Branch, Assiut71524, Egypt.
  • 7 Department of Physics, Faculty of Science, Sohag University, Sohag82524, Egypt.
  • 8 Department of Medicinal Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef62514, Egypt.
  • 9 Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, Taif21944, Saudi Arabia.
  • 10 Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra11961, Saudi Arabia.
  • 11 Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, South Valley University, Qena83523, Egypt.
  • 12 Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Shaqra11961, Saudi Arabia.
Abstract

Microwave-assisted synthesis and spectral analysis of certain novel derivatives of 3,4-diaminothieno[2,3-b]thiophene-2,5-dicarbonitrile 1-7 were carried out. Compounds 1-7 were examined for cytotoxicity against MCF-7 and A549 cell lines using the quantitative MTT method, and gefitinib and erlotinib were used as Reference Standards. Compounds 1-7 were shown to be more active than erlotinib against the two cell lines tested. Compound 2 outperformed regular erlotinib by 4.42- and 4.12-fold in MCF-7 and A549 cells, respectively. The most cytotoxic compounds were subsequently studied for their suppression of kinase activity using the homogeneous time-resolved fluorescence assay versus epidermal growth factor receptor (EGFRWT) and EGFR790M. With IC50 values of 0.28 ± 0.03 and 5.02 ± 0.19, compound 2 was demonstrated to be the most effective against both forms of EGFR. Furthermore, compound 2 also had the best antioxidant property, decreasing the radical scavenging activity by 78%. Molecular docking research, on the other hand, was carried out for the analyzed candidates (1-7) to study their mechanism of action as EGFR inhibitors. In silico absorption, distribution, metabolism, excretion, and toxicity tests were also performed to explain the physicochemical features of the examined derivatives.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-152144
    EGFRWT/EGFRT790M Inhibitor